1.73
price up icon0.00%   0.00
after-market Handel nachbörslich: 1.76 0.03 +1.73%
loading

Eledon Pharmaceuticals Inc Aktie (ELDN) Neueste Nachrichten

pulisher
Jan 08, 2026

Can Eledon Pharmaceuticals Inc. stock sustain market leadershipJuly 2025 Retail & Risk Adjusted Buy and Sell Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Eledon’s tegoprubart shows promise in kidney transplantation trials By Investing.com - Investing.com South Africa

Jan 08, 2026
pulisher
Jan 08, 2026

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook - The Manila Times

Jan 08, 2026
pulisher
Jan 08, 2026

Can Eledon Pharmaceuticals Inc. stock sustain revenue growthJuly 2025 Update & Verified Entry Point Signals - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Eledon Pharmaceuticals (NASDAQ:ELDN) Trading Up 3% – Time to Buy? - Defense World

Jan 08, 2026
pulisher
Jan 07, 2026

Is Eledon Pharmaceuticals Inc. (2TK) stock a defensive play amid uncertaintyCandlestick Pattern Analysis & Free Expert Stock Watchlists - ulpravda.ru

Jan 07, 2026
pulisher
Jan 05, 2026

Midday Stock Roundup: Lantronix Stock up 4.8% Today - Orange County Business Journal

Jan 05, 2026
pulisher
Jan 02, 2026

Eledon Pharmaceuticals restructures stake via pre-funded warrant - MSN

Jan 02, 2026
pulisher
Jan 02, 2026

Eledon Pharmaceuticals Restructures Stake via Pre-Funded Warrant - TipRanks

Jan 02, 2026
pulisher
Jan 02, 2026

Midday Stock Roundup: Rivian Down on Production Totals - Orange County Business Journal

Jan 02, 2026
pulisher
Jan 01, 2026

Eledon Pharmaceuticals (ELDN) Price Target Decreased by 14.93% to 8.33 - MSN

Jan 01, 2026
pulisher
Dec 31, 2025

Eledon Pharmaceuticals (STU:2TK) EV-to-OCF : -0.29 (As of Dec. 31, 2025) - GuruFocus

Dec 31, 2025
pulisher
Dec 31, 2025

The End of Shots? 5 Biotech Stocks Rethinking Diabetes - Morningstar

Dec 31, 2025
pulisher
Dec 29, 2025

Is Eledon Pharmaceuticals Inc. (2TK) stock a buy during volatile marketsProtective Put Strategies & Small Capital Growth Tips - bollywoodhelpline.com

Dec 29, 2025
pulisher
Dec 28, 2025

Midday Stock Roundup: Shimmick Corp. climbs 14% - Orange County Business Journal

Dec 28, 2025
pulisher
Dec 26, 2025

Sector Rotation Brings Aditya Birla Sun Life Amc Ltd Into FocusSmall Cap Stock Opportunities & Free ETF and Mutual Fund Comparisons - earlytimes.in

Dec 26, 2025
pulisher
Dec 24, 2025

Why Is Eledon Pharmaceuticals Stock (ELDN) Down 50% Today? - MSN

Dec 24, 2025
pulisher
Dec 23, 2025

Can Eledon Pharmaceuticals Inc. stock double in next 5 yearsStochastic Oscillator Alerts & Free High Yield Growth Strategies - Bollywood Helpline

Dec 23, 2025
pulisher
Dec 22, 2025

Eledon Pharmaceuticals Inc (ELDN) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com

Dec 22, 2025
pulisher
Dec 20, 2025

Analysts Set Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Target Price at $9.67 - Defense World

Dec 20, 2025
pulisher
Dec 19, 2025

Midday Stock Roundup: Rivian Stock Continues to Climb - Orange County Business Journal

Dec 19, 2025
pulisher
Dec 19, 2025

Eledon Pharmaceuticals Earnings Notes - Trefis

Dec 19, 2025
pulisher
Dec 17, 2025

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Receives Average Rating of "Hold" from Analysts - MarketBeat

Dec 17, 2025
pulisher
Dec 12, 2025

Midday Stock Roundup: Rivian Rises on Chip, Models - Orange County Business Journal

Dec 12, 2025
pulisher
Dec 11, 2025

Eledon prices $50 million public offering of stock and warrants By Investing.com - Investing.com Nigeria

Dec 11, 2025
pulisher
Dec 10, 2025

Net current asset value per share of Eledon Pharmaceuticals, Inc. – DUS:2TK - TradingView — Track All Markets

Dec 10, 2025
pulisher
Dec 08, 2025

Kidney Transplant Rejection Market on Track for Major Expansion by 2034, According to DelveInsight | GE Healthcare, Viela Bio, Eledon Pharma, Neovii Biotech, GlaxoSmithKline, Novartis, Medeor - Barchart.com

Dec 08, 2025
pulisher
Dec 08, 2025

Kidney Transplant Rejection Market on Track for Major Expansion - openPR.com

Dec 08, 2025
pulisher
Dec 07, 2025

Eledon Pharmaceuticals Inc Stock Analysis and ForecastPrice-to-Earnings Ratio Insights & Free Stock Index Interpretations - earlytimes.in

Dec 07, 2025
pulisher
Dec 05, 2025

Why Eledon Pharmaceuticals Inc. stock is favored by pension fundsQuarterly Portfolio Review & Daily Profit Focused Screening - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

How analysts revise price targets for Eledon Pharmaceuticals Inc. (2TK) stockRisk Management & High Conviction Trade Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Published on: 2025-12-04 05:40:36 - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why Eledon Pharmaceuticals Inc. (2TK) stock could be top winnerJuly 2025 Movers & Daily Risk Controlled Trade Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Is Eledon Pharmaceuticals Inc. (2TK) stock attractive post correctionBond Market & Verified High Yield Trade Plans - Newser

Dec 04, 2025
pulisher
Dec 02, 2025

Why Eledon Pharmaceuticals Inc. (2TK) stock stays on buy lists2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Eledon Pharmaceuticals (ELDN) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 01, 2025

Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference - The Manila Times

Dec 01, 2025
pulisher
Nov 30, 2025

What drives Eledon Pharmaceuticals Inc stock priceInflation Impact on Stocks & Capital Growth Strategies - earlytimes.in

Nov 30, 2025
pulisher
Nov 28, 2025

Midday Stock Roundup: Eledon Up 4.8% - Orange County Business Journal

Nov 28, 2025
pulisher
Nov 27, 2025

FY2025 Earnings Forecast for ELDN Issued By Leerink Partnrs - MarketBeat

Nov 27, 2025
pulisher
Nov 25, 2025

United StatesMintz Advises On Eledon Pharmaceuticals’ $50 Million Follow-on Offering - Mondaq

Nov 25, 2025
pulisher
Nov 24, 2025

Eledon Shares Fall Nearly 50% After Phase 2 Results - Orange County Business Journal

Nov 24, 2025
pulisher
Nov 24, 2025

What is Eledon Pharmaceuticals Inc (ELDN) Stock Return on Shareholders’ Capital? - setenews.com

Nov 24, 2025
pulisher
Nov 23, 2025

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Nov 23, 2025
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Kapitalisierung:     |  Volumen (24h):